Answers are grounded in this paper and cite their sources.
These findings show that although an excess of cardiac and systemic Gal-3 is present in patients with HF of hypertensive origin, this molecule is not associated with histological, molecular and biochemical parameters related to myocardial fibrosis in these patients.
No takes yet. Share an insight, caveat, or question.
López et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: